PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology
A 10-week virtual accelerator offering pharma education, personalized mentoring, direct pharma access, and investment for digital health startups worldwide focusing on immunology.
- Funding amount
- Varies by program
- Funding type
- Equity
- Provider
- PharmStars (Accelerator)
- Application deadline
- Closed (12 Jul 2026)
- Eligible stage
- Any stage
- Location
- Open to startups registered in India
Overview
PharmStars, a leading pharma-focused accelerator, runs this virtual 10-week program to connect innovative digital health startups with pharmaceutical and biotech companies. The Fall 2026 cohort focuses on "Digital Innovations in Immunology," seeking solutions for autoimmune diseases, inflammatory conditions, allergies, and asthma. The program features a specialized PharmaU curriculum that teaches startups about drug development, pharma business models, regulatory drivers, and deal structures. Participants receive personalized mentoring from former pharma executives, direct access to pharma partners, and an investment from the PharmStars Ventures Fund. The accelerator concludes with a Startup Showcase where startups pitch to key industry players. With ten successful cohorts and over 112 graduated startups that have raised more than $1 billion cumulatively, PharmStars has a proven track record of fostering collaborations that accelerate digital health adoption and improve patient outcomes.
Highlights
- Virtual 10-week accelerator
- Focus on Digital Innovations in Immunology
- Investment from PharmStars Ventures Fund
- Personalized mentoring
- Direct pharma access
- Global startups eligible
Who can apply
Digital health startups from anywhere in the world are eligible if they have a market-ready product or prototype that addresses the "Digital Innovations in Immunology" theme. Solutions can cover disease prevention, diagnosis, treatment, monitoring, or patient care for immune system conditions. Applicants should be interested in collaborating with pharmaceutical and biotech firms to accelerate patient outcomes. There are no restrictions on company stage, industry sub-sector, state, entity type, or DPIIT/MSME registration.
PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology is open to startups at any stage. It is open to startups registered anywhere in India.
- Eligible stage
- Any stage
- Location
- Open to startups registered in India
Deadline & timing
The most recent application window for PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology closed on 12 Jul 2026. Many programmes run repeat cohorts, so it is worth checking the official site for the next round.
What the funding covers
Selected startups receive an investment from the PharmStars Ventures Fund. In addition to funding, the program offers a 10-week virtual accelerator that includes the PharmaU curriculum (covering drug development, pharma structures, and deal negotiation), personalized mentoring from former pharma executives, direct access to pharmaceutical and biotech companies, and a Startup Showcase to present solutions to industry players, accelerating partnership opportunities.
About the provider
PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology is offered by PharmStars, a startup accelerator. It is delivered directly by PharmStars as a equity. You can verify current details and timelines on the provider's official website before applying.
How to apply
Applications are submitted on the official portal. Confirm the current deadline and document checklist there before you start.
Selection process
Applications are reviewed by a specialized selection committee of PharmStars' experienced former pharma executives and representatives from their pharma member network. They prioritize market-ready solutions that strongly align with the immunology theme and show potential for successful partnerships with pharma companies. Shortlisted startups may be invited for further discussions, presentations, or interviews to assess fit and readiness. Final acceptance decisions are communicated by August 26, 2026.
Documents you’ll need
Before you apply to PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology, keep the following documents ready:
- A pitch deck or short business plan describing the problem, product and traction
- Company registration documents and PAN
- Founder identification (PAN / Aadhaar) and brief profiles
- Recent financial statements or projections
- Product details — a demo, prototype or working link if available
Exact requirements are confirmed on the official application portal — treat this as a preparation checklist.
Frequently asked questions
How much funding does the PharmStars Fall 2026 Accelerator provide?
The accelerator offers an investment from the PharmStars Ventures Fund to selected startups. The exact amount is not specified and varies per startup.
What is the application deadline?
Applications opened on June 1, 2026, and must be submitted online by July 12, 2026.
Who is eligible to apply?
Digital health startups worldwide with market-ready products or prototypes focusing on immunology innovations are eligible. There are no geographic restrictions or requirements for DPIIT or MSME registration.
Does the accelerator take equity?
Yes, this is an equity-based funding program. The PharmStars Ventures Fund invests in exchange for an equity stake in the startup.
What is the program structure?
The program is a 10-week virtual accelerator that includes the PharmaU curriculum, personalized mentoring, direct pharma access, and a Startup Showcase. It runs virtually with a launch event on September 9-10, 2026.
What types of digital health solutions are you looking for?
The cohort theme is "Digital Innovations in Immunology." We seek solutions addressing immune system conditions such as autoimmune diseases, inflammatory conditions, allergies, and asthma. This includes improving patient identification, diagnosis, personalized treatment, disease monitoring, drug development, safety, and patient access.
Can early-stage startups apply?
The program requires market-ready solutions with a product or prototype. While early-stage startups with a prototype are eligible, the program is best suited for startups that have advanced beyond the ideation stage.
How are startups selected?
Applications are reviewed by a committee of former pharma executives and pharma member representatives. They evaluate alignment with the immunology theme, market readiness, and partnership potential. Shortlisted startups may be interviewed. Final decisions are communicated by August 26, 2026.
What documents are needed to apply?
Applicants must submit all required documents as specified in the Accelerator Terms. These typically include a completed application form, pitch deck, and possibly other supporting materials. Details are provided on the official application portal.
How do I apply?
Applications are submitted online through the official PharmStars application portal at https://www.pharmstars.com/applyarch.
Is DPIIT recognition required for PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology?
No. DPIIT (Startup India) recognition is not listed as a mandatory requirement for PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology, though having it can strengthen your application and unlock other benefits.
Who offers PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology?
PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology is offered by PharmStars, a startup accelerator. It is provided as an investment.
Alternatives to PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology
Not sure PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology is the right fit, or already applied? These are other equity open to Indian startups that founders shortlist alongside it.
Questions from founders
Ask anything about eligibility, documents or the process — answered by the community.
No questions yet — be the first to ask.